KR890014117A - 트롬복산 a₂ 리셉터 길항질을 사용하여 체외 순환중 혈소판 감손을 억제 또는 감소시키는 방법 - Google Patents
트롬복산 a₂ 리셉터 길항질을 사용하여 체외 순환중 혈소판 감손을 억제 또는 감소시키는 방법 Download PDFInfo
- Publication number
- KR890014117A KR890014117A KR1019890002731A KR890002731A KR890014117A KR 890014117 A KR890014117 A KR 890014117A KR 1019890002731 A KR1019890002731 A KR 1019890002731A KR 890002731 A KR890002731 A KR 890002731A KR 890014117 A KR890014117 A KR 890014117A
- Authority
- KR
- South Korea
- Prior art keywords
- thromboxane
- extracorporeal circulation
- inhibit
- methods
- receptor antagonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
내용 없음.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
첨부 도면은 바이패스 수술 중 혈소판 감손에 대한 정맥내 주사한 트롬복산 A₂ 길항질(SQ 30,741)의 효과를 나타내는 그래프임.
Claims (3)
- 트롬복산 A₂ 리셉터 길항질 단독이나 또는 프로스타시클린 및(또는) 프로스타시클린 모사물과의 혼합물의 체외 순환중 혈소판 감손을 억제 또는 감소시키기 위한 의약품 제조 용도.
- 체외 순환 중 혈소판 감손을 억제 또는 감소시키기 위한 용도의 트롬복산 A₂ 리셉터 길항질 단독이나 또는 프로스타시클린 및(또는) 프로스타시클린 모사물의 혼합물.
- 트롬복산 A₂ 리셉터 길항질을 단독으로 또는 프로스타시클린 또는 프로스타시클린 모사물과 함께 함유하는, 체외 순환 중 혈소판 감손을 억제 또는 감소시키기 위한 조성물.※ 참고사항:최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US165,065 | 1980-07-01 | ||
US07/165,065 US4820733A (en) | 1988-03-07 | 1988-03-07 | Method of preventing or reducing platelet loss during extracorporeal circulation using a thromboxane A2 receptor antagonist |
Publications (1)
Publication Number | Publication Date |
---|---|
KR890014117A true KR890014117A (ko) | 1989-10-21 |
Family
ID=22597267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019890002731A KR890014117A (ko) | 1988-03-07 | 1989-03-06 | 트롬복산 a₂ 리셉터 길항질을 사용하여 체외 순환중 혈소판 감손을 억제 또는 감소시키는 방법 |
Country Status (11)
Country | Link |
---|---|
US (1) | US4820733A (ko) |
EP (1) | EP0332306A3 (ko) |
JP (1) | JPH01272525A (ko) |
KR (1) | KR890014117A (ko) |
AU (1) | AU626829B2 (ko) |
CA (1) | CA1334167C (ko) |
DK (1) | DK106889A (ko) |
HU (1) | HU208627B (ko) |
IL (1) | IL89256A0 (ko) |
PH (1) | PH25182A (ko) |
ZA (1) | ZA891038B (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4010536A1 (de) * | 1990-04-02 | 1991-10-10 | Boehringer Mannheim Gmbh | Pharmazeutische waessrige loesung von 4-(2-(benzolsulfonylamino)-ethyl)-phenoxyessigsaeure |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3526362A1 (de) * | 1985-07-19 | 1987-01-22 | Schering Ag | Prostacycline, ihre analoga oder prostaglandine und thromboxanantagonisten zur behandlung von thrombotischen und thromboembolischen krankheitsbildern |
-
1988
- 1988-03-07 US US07/165,065 patent/US4820733A/en not_active Expired - Lifetime
-
1989
- 1989-02-09 CA CA000590648A patent/CA1334167C/en not_active Expired - Fee Related
- 1989-02-09 ZA ZA891038A patent/ZA891038B/xx unknown
- 1989-02-10 IL IL89256A patent/IL89256A0/xx unknown
- 1989-02-16 PH PH38206A patent/PH25182A/en unknown
- 1989-02-16 EP EP89301512A patent/EP0332306A3/en not_active Withdrawn
- 1989-02-22 AU AU30208/89A patent/AU626829B2/en not_active Ceased
- 1989-03-06 HU HU891100A patent/HU208627B/hu not_active IP Right Cessation
- 1989-03-06 DK DK106889A patent/DK106889A/da not_active Application Discontinuation
- 1989-03-06 KR KR1019890002731A patent/KR890014117A/ko not_active Application Discontinuation
- 1989-03-07 JP JP1054835A patent/JPH01272525A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU3020889A (en) | 1989-09-07 |
AU626829B2 (en) | 1992-08-13 |
JPH01272525A (ja) | 1989-10-31 |
DK106889D0 (da) | 1989-03-06 |
HU208627B (en) | 1993-12-28 |
ZA891038B (en) | 1989-10-25 |
DK106889A (da) | 1989-09-08 |
EP0332306A2 (en) | 1989-09-13 |
US4820733A (en) | 1989-04-11 |
IL89256A0 (en) | 1989-09-10 |
CA1334167C (en) | 1995-01-31 |
EP0332306A3 (en) | 1990-08-22 |
HUT49483A (en) | 1989-10-30 |
PH25182A (en) | 1991-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR900701261A (ko) | 비만증 치료방법 | |
KR900004352A (ko) | 뇌졸중 치료용 의약 | |
GT199800126A (es) | Terapia de combinacion. | |
EP0217206A3 (en) | Medicament against chronic graft-versus-host diseases, as well as against autoimmune diseases, particularly systemic lupus erythematodes | |
ES513485A0 (es) | "procedimiento de preparacion de una composicion terapeutica en la que el unico agente hemostatico activado efectivo sea el factor viia". | |
KR910016317A (ko) | 이온전기도입에 의한 딜리버리를 증가시키는 방법 및 여기에 사용되는 조성물 | |
ES2170171T3 (es) | Composicion de liberacion controlada que forma una estructura micelar inversa (l2) o una estructura micelar normal (l1). | |
KR910000703A (ko) | 테트라졸 자극성 아미노산 수용체의 길항물질 | |
KR900702081A (ko) | 1, 1-디클로로-1-플루오로에탄/에탄올계 공비성조성물 | |
KR900002802A (ko) | 면역억제제로서의 트랜스글루타미나제의 용도 | |
KR890014117A (ko) | 트롬복산 a₂ 리셉터 길항질을 사용하여 체외 순환중 혈소판 감손을 억제 또는 감소시키는 방법 | |
KR890013109A (ko) | 난연성, 열가소성 탄성중합체 조성물 | |
KR910000130A (ko) | 진경제 | |
ATE188692T1 (de) | Fibrinogenrezeptorantagonisten | |
DK578887D0 (da) | Antihypertensiva | |
KR920021144A (ko) | 역류성 식도염을 치료하기위한 니자티딘의 용도 | |
DE3875349D1 (de) | Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie. | |
KR890001540A (ko) | 심부전증 치료제 | |
DK0651614T3 (da) | Stabiliseret fødevaresammensætning | |
KR880005926A (ko) | 알파-2i 선택성 아드레날린 수용체 작용제로 되어 있는 기억력 향상용 치료제 | |
KR890007728A (ko) | 진통제 제조방법 | |
KR880009656A (ko) | 국소 치근막 질환의 치료 또는 예방법 | |
KR960003718A (ko) | 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용 | |
KR880000094A (ko) | 위염치료제 | |
KR920019349A (ko) | 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |